My watch list
my.chemeurope.com  
Login  

Beclamide



Beclamide
Systematic (IUPAC) name
N-benzyl-3-chloropropionamide
Identifiers
CAS number 501-68-8
ATC code N03AX30
PubChem 10391
Chemical data
Formula  ?
Mol. mass  ?
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes Oral

Beclamide (marketed as Chloracon, Hibicon, Posedrine, Nydrane, Seclar, and other names) is a propionate and was used as a sedative and as an anticonvulsant.

Additional recommended knowledge

Side effects are uncommon but include stomach pain, nervousness, giddiness, skin rash and leukopenia. It is counter-indicated in breast feeding as it is passed in the milk.

Administration is oral, though it has an unpleasant taste. It is quickly absorbed and elimination is renal and complete within 48 hours.

It was studied in the 1950s for its anticonvulsant properties, as a treatment for generalised tonic-clonic seizures. It was not effective for absence seizures. It is no longer used as an AED. Interest in the drug resumed in the 1990s for its psychiatric properties as an adjunct in the treatment of schizophrenia.

References

  • The Medical Treatment of Epilepsy by Stanley R Resor. Published by Marcel Dekker (1991). ISBN 0-8247-8549-5.
  • Beclamide (in French)


 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Beclamide". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE